Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
1.425
+0.025 (1.79%)
At close: Feb 27, 2026, 4:00 PM EST
1.410
-0.015 (-1.05%)
After-hours: Feb 27, 2026, 6:16 PM EST
Akso Health Group Revenue
Akso Health Group had revenue of $7.00M in the half year ending September 30, 2025, with 683.21% growth. This brings the company's revenue in the last twelve months to $14.84M, up 75.55% year-over-year. In the fiscal year ending March 31, 2025, Akso Health Group had annual revenue of $14.78M with 512.08% growth.
Revenue (ttm)
$14.84M
Revenue Growth
+75.55%
P/S Ratio
82.25
Revenue / Employee
$549,713
Employees
27
Market Cap
1.22B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 397.96B |
| Cencora | 325.78B |
| Cardinal Health | 244.67B |
| Henry Schein | 13.18B |
| Accendra Health | 2.76B |
| 111, Inc. | 1.91B |
| Quipt Home Medical | 264.97M |
| EDAP TMS | 74.85M |
AHG News
- 25 days ago - Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative - PRNewsWire
- 1 year ago - AHG Utilizes DeepSeek to Advance AI in Healthcare - PRNewsWire
- 2 years ago - AHG Announces Plan to Acquire Online Clinic - GlobeNewsWire
- 2 years ago - Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement - GlobeNewsWire
- 3 years ago - Akso Health Group Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule - GlobeNewsWire
- 3 years ago - Akso Health Group Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency - GlobeNewsWire
- 3 years ago - Akso Health Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - PRNewsWire
- 3 years ago - Akso Health Group Receives Notice of Filing Delinquency From Nasdaq - PRNewsWire